{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-013776","form_type":"8-K","ticker":"COCP","cik":"0001412486","company_name":"Cocrystal Pharma, Inc.","filed_at":"2025-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.212004+00:00","generated_at":"2026-05-19T21:41:05.358185+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Cocrystal Pharma's norovirus antiviral CDI-988 to be presented at MHSRS in August 2025","bullets":["CDI-988, a broad-spectrum protease inhibitor, will be featured in an oral presentation at the 2025 Military Health System Research Symposium on August 4, 2025 in Kissimmee, Florida.","Cocrystal is developing CDI-988 as a norovirus prophylaxis and treatment; no approved antivirals or vaccines for norovirus currently exist.","President and co-CEO Sam Lee, PhD, will discuss Phase 1 safety, tolerability, and pharmacokinetics results at the conference.","CDI-988 targets a highly conserved region in 3CL viral proteases, potentially halting infection early regardless of viral strain or mutation.","Norovirus spreads rapidly in confined spaces like military settings, posing a threat to operational effectiveness and economic burden."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-013776","json":"https://secwatch.observer/filing/0001641172-25-013776.json","markdown":"https://secwatch.observer/filing/0001641172-25-013776.md","text":"https://secwatch.observer/filing/0001641172-25-013776.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1412486/000164117225013776/0001641172-25-013776-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1412486/000164117225013776/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T21:41:05.358185+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}